Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04964375
Title A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Abbisko Therapeutics Co, Ltd
Indications

Advanced Solid Tumor

melanoma

Therapies

ABSK043

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST